Source:http://linkedlifedata.com/resource/pubmed/id/11085586
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
2001-3-8
|
pubmed:abstractText |
Preventive and/or therapeutic vaccines against Human Immunodeficiency Virus (HIV-1) are urgently required. Induction of cellular immunity is favoured since these responses correlate with control of HIV-1. Recombinant fowlpoxvirus (FPV) vaccines encoding both HIV-1 gag/pol and interferon-gamma (FPV gag/pol-IFNgamma) were hypothesised to enhance HIV-specific cellular immunity and were further evaluated in macaques previously infected with HIV-1. A novel assay to detect IFNgamma secretion following HIV antigen stimulation of whole blood was developed to further assess the safety and immunogenicity of the FPV gag/pol-IFNgamma vaccine. Immunisation with FPV gag/pol-IFNgamma safely enhanced HIV-specific IFNgamma secretion following ex vivo stimulation of whole blood, greater than that observed following FPV gag/pol vaccination not co-expressing IFNgamma. Both HIV-specific IFNgamma-spot-forming cells by ELISPOT and CD69 expression by CD4+ lymphocytes were also enhanced following FPV gag/pol-IFNgamma vaccination. Hence, the FPV-HIV vaccine co-expressing IFNgamma stimulated HIV-specific T cell responses in macaques, and should be further evaluated as a therapeutic or preventive HIV vaccine.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AIDS Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/CD69 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins, C-Type,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidine Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Synthetic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0047-2565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
240-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11085586-AIDS Vaccines,
pubmed-meshheading:11085586-Animals,
pubmed-meshheading:11085586-Antigens, CD,
pubmed-meshheading:11085586-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:11085586-Fowlpox virus,
pubmed-meshheading:11085586-Genes, gag,
pubmed-meshheading:11085586-Genes, pol,
pubmed-meshheading:11085586-HIV-1,
pubmed-meshheading:11085586-Humans,
pubmed-meshheading:11085586-Interferon-gamma,
pubmed-meshheading:11085586-Lectins, C-Type,
pubmed-meshheading:11085586-Macaca nemestrina,
pubmed-meshheading:11085586-Safety,
pubmed-meshheading:11085586-T-Lymphocytes,
pubmed-meshheading:11085586-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:11085586-Thymidine Kinase,
pubmed-meshheading:11085586-Time Factors,
pubmed-meshheading:11085586-Vaccines, Synthetic
|
pubmed:year |
2000
|
pubmed:articleTitle |
Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma.
|
pubmed:affiliation |
AIDS Pathogenesis Research Unit, Macfarlane Burnet Centre for Medical Research, Fairfield, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|